The Spanish Agency of Medicines and Medical Devices (AEMPS) has also approved ARI-001, a CD19 CAR-T cell, for adult patients with B-ALL (Ortíz-Maldonado et al., 2021). This evidence concerns the gene CD19 and acute lymphoblastic leukemia.